Furthermore, the in vivo study revealed that knockdown of NRF2 markedly decreased the protein levels (Figure S15D) and enzymatic activities (Figure 5I-J) of G6PD and TKT in the excised tumors from Ca9-22-D1 xenograft tumor-bearing mice. The gene discussed is G6PD; the disease is neoplasm.